July 12, 2012 13:45 ET

Global Market for X-Rays to Spike to Over $9.0 Billion by 2017

NEW YORK, NY--(Marketwire - Jul 12, 2012) - cites in its newly published "Medical Imaging Markets" report that the global market for X-rays will spike to over $9.0 billion by 2017. For more information, visit:

Medical imaging can be categorized into nine main modalities: X-ray, ultrasound, computed tomography (CT), positron emission tomography (PET), single photon emission tomography (SPECT), magnetic resonance imaging (MRI), nuclear medicine (NM), mammography and fluoroscopy. X-rays comprise 32%, the largest share of the global medical imaging market. North America was the largest single market for medical imaging in 2011, valued at $6.4 billion and representing 27% of the global medical imaging market.

The "Medical Imaging Markets" report covers:

  • Hybrid Modalities
  • Digital Radiography/Computed Radiography (DR/CR)
  • Image-Guided Radiation Therapy (IGRT)
  • CT Angiography
  • Optical Coherence Tomography (OCT)
  • Diagnostic Imaging Hardware
  • Diagnostic Imaging Software
  • Global Oncology Biomarkers Market
  • U.S. Healthcare Reform

The "Medical Imaging Markets" report examines companies manufacturing medical imaging equipment and supplies in the world. Companies covered include: 3mensio, Agfa, Analogic, Ardent Sound, Avreo, Bard Access, BK, BRIT, Candelis, Canon, Cedaron, Chison, DR, Esaote, Focus Surgery, Fonar, Fujifilm, Fukuda Denshi, GE, Hermes, Hitachi, Hologic, Imaging Diagnostic, InfiMed, Intelerad, Invivo, Konica Minolta, Lantheus, Lumedx, MEDIAN, Medis, Medtronic, NanoScan, NovaRad, Philips, Positron, Samsung Medison, Schick, ScImage, Sectra, Shimadzu, Siemens, SonoSite, Spacelabs, Syntermed, TeraMedica, TeraRecon, Phantom, TomTec, Toshiba, UltraRAD, Varian, Vepro, Vidar, Vital, VuCOMP, Xoran and ZONARE.

Detailed charts with sales forecasts and marketshare data are included. For more information, visit:

About is a global leader in the biotechnology, healthcare and life sciences market research publishing. For more information, please visit

Important Notice

The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.

Contact Information